CuraTeQ Biologics, a wholly-owned subsidiary of the Indian pharmaceutical giant Aurobindo Pharma, announced this week that it has received a Notice of Compliance (NOC) from Health Canada for its Bevacizumab biosimilar. This regulatory milestone, granted in early 2024, authorizes the company to market its version of the therapeutic protein, which is widely used in the…
Global regulators are reviewing pharmaceutical and medical device supply chains to boost resilience and ensure patient access to vital health products.
Market Rebound Driven by Robust Performance Eli Lilly and Company shares surged on Thursday after the pharmaceutical giant reported third-quarter financial results that significantly exceeded Wall Street expectations. The company, headquartered in Indianapolis, announced a comprehensive “beat-and-raise” performance, effectively reversing a recent period of stock price volatility that had left investors questioning the firm’s near-term…
